Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Asset Writedowns and Impairment (2016 - 2025)

Merit Medical Systems' Asset Writedowns and Impairment history spans 14 years, with the latest figure at $161000.0 for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 192.73% year-over-year to $161000.0; the TTM value through Dec 2025 reached $313000.0, down 31.36%, while the annual FY2025 figure was $313000.0, 31.36% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $161000.0 at Merit Medical Systems, up from $70000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.7 million in Q1 2022 and bottomed at $32000.0 in Q1 2025.
  • The 5-year median for Asset Writedowns and Impairment is $74000.0 (2024), against an average of $233714.3.
  • The largest annual shift saw Asset Writedowns and Impairment tumbled 99.79% in 2021 before it skyrocketed 192.73% in 2025.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $44000.0 in 2021, then skyrocketed by 1145.45% to $548000.0 in 2022, then plummeted by 91.79% to $45000.0 in 2023, then increased by 22.22% to $55000.0 in 2024, then surged by 192.73% to $161000.0 in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Asset Writedowns and Impairment are $161000.0 (Q4 2025), $70000.0 (Q3 2025), and $50000.0 (Q2 2025).